From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

Researchers found no association between anti-U1RNP autoantibodies and 3-year ILD progression or mortality in patients with ...

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis: Zug, Switzerland Friday, June 27, 2025, 13:00 Hr ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...

“Professor Mellerio brings an important clinical voice to the NETHERTON NOW series,” said Denise Carter, Co-Founder and Chief Operating Officer of Quoin Pharmaceuticals. “Her experience treating ...

Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...

It sounds like alchemy: doctors treating rheumatoid arthritis with the beloved base metal gold. Popularized in the 1920s by ...

People with scleroderma can experience skin tightening and rashes. Image: Shutterstock. In Mithi’s case, the early signs included Raynaud’s phenomenon, reflux, weight loss and muscle wasting ...

Over the past four and a half years immunity to Covid-19 has increased and the disease is mild for most people. However with it still occurring regularly in Wales older people are the most vulnerable ...

FULL HOUSE might be massively popular, but there’s one person who’s not familiar with the show — star Jodie Sweetin!